Literature DB >> 19712107

Structural disorder in amyloid fibrils: its implication in dynamic interactions of proteins.

P Tompa1.   

Abstract

Proteins are occasionally converted from their normal soluble state to highly ordered fibrillar aggregates (amyloids), which give rise to pathological conditions that range from neurodegenerative disorders to systemic amyloidoses. Recent methodological advances in solid-state NMR and EPR spectroscopy have enabled determination of the 3D structure of several amyloids at residue-level resolution. The general picture that emerges is that amyloids constitute parallel beta sheets, in which individual polypeptide chains run roughly perpendicular to the major axis of the fibril and are stacked in-register. Thus, the unifying theme of amyloid formation is the structural transition from an initial globular or intrinsically disordered state to a highly ordered regular form. In this minireview, we show that this description is somewhat oversimplified, because part of the polypeptide chain in the amyloid remains intrinsically disordered and does not become part of the ordered core. As demonstrated through examples such as the amyloids of alpha-synuclein and Abeta peptide and the yeast prions HET-s and Ure2p, these disordered segments are depleted in amino acids NQFYV and are enriched in DEKP. They are also significantly more charged and have a higher predicted disordered value than segments in the cross-beta core. We suggest that structural disorder in amyloid is a special case of 'fuzziness', i.e. disorder in the bound state that may serve different functions, such as the accommodation of destabilizing residues and the mediation of secondary interactions between protofibrils.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712107     DOI: 10.1111/j.1742-4658.2009.07250.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  27 in total

1.  Distinct hydration properties of wild-type and familial point mutant A53T of α-synuclein associated with Parkinson's disease.

Authors:  E Hazy; M Bokor; L Kalmar; A Gelencser; P Kamasa; K-H Han; K Tompa; P Tompa
Journal:  Biophys J       Date:  2011-11-01       Impact factor: 4.033

2.  Amyloid and Alzheimer's disease.

Authors:  Hongxing Lei
Journal:  Protein Cell       Date:  2010-04       Impact factor: 14.870

Review 3.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

4.  Amyloid fibers provide structural integrity to Bacillus subtilis biofilms.

Authors:  Diego Romero; Claudio Aguilar; Richard Losick; Roberto Kolter
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

5.  Conserved core of amyloid fibrils of wild type and A30P mutant α-synuclein.

Authors:  Min-Kyu Cho; Hai-Young Kim; Claudio O Fernandez; Stefan Becker; Markus Zweckstetter
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

6.  Unfolding of metastable linker region is at the core of Hsp33 activation as a redox-regulated chaperone.

Authors:  Claudia M Cremers; Dana Reichmann; Jens Hausmann; Marianne Ilbert; Ursula Jakob
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

7.  The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency.

Authors:  Jeffrey R Brender; Ravi Prakash Reddy Nanga; Nataliya Popovych; Ronald Soong; Peter M Macdonald; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2011-01-22

8.  Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment.

Authors:  Ravi Prakash Reddy Nanga; Jeffrey R Brender; Subramanian Vivekanandan; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2011-06-23

9.  Facilitated aggregation of FG nucleoporins under molecular crowding conditions.

Authors:  Sigrid Milles; Khanh Huy Bui; Christine Koehler; Mikhail Eltsov; Martin Beck; Edward A Lemke
Journal:  EMBO Rep       Date:  2012-12-14       Impact factor: 8.807

Review 10.  Intrinsically disordered proteins are potential drug targets.

Authors:  Steven J Metallo
Journal:  Curr Opin Chem Biol       Date:  2010-07-02       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.